cyclizine has been researched along with chlorcyclizine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashford, A; Ashton, MJ; Loveless, AH; Riddell, D; Salmon, J; Stevenson, GV | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T | 1 |
| Dulcey, AE; Ferrer, M; He, S; Hu, X; Hu, Z; Liang, TJ; Lin, B; Marugan, JJ; Rolt, A; Southall, N; Wang, AQ; Xiao, J; Xu, X; Zheng, W | 1 |
| Kabir, M; Kerns, E; Nguyen, K; Shah, P; Sun, H; Wang, Y; Xu, X; Yu, KR | 1 |
| CRACOVANER, AJ; GOULD, WJ; GUTNER, LB | 1 |
| COON, JM; WELCH, RM | 1 |
| MACDONALD, A; PFLAUM, RT | 1 |
| BURNS, JJ; KLUTCH, A; KUNTZMAN, R; TSAI, I | 1 |
10 other study(ies) available for cyclizine and chlorcyclizine
| Article | Year |
|---|---|
Heterocyclic analogues of chlorcyclizine with potent hypolipidemic activity.
Topics: Animals; Body Weight; Chemical Phenomena; Chemistry; Cholesterol, Dietary; Eating; Hypolipidemic Agents; Indicators and Reagents; Male; Piperazine; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1984 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics | 2012 |
Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection.
Topics: Dose-Response Relationship, Drug; Drug Discovery; Hepacivirus; Hepatitis C; Microbial Sensitivity Tests; Molecular Structure; Piperazines; Structure-Activity Relationship | 2016 |
Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
Topics: Drug Discovery; Organic Chemicals; Pharmaceutical Preparations; Solubility | 2019 |
Effects of cyclizine hydrochloride and chlorcyclizine hydrochloride upon vestibular function.
Topics: Anti-Allergic Agents; Cyclizine; Ear, Inner; Histamine H1 Antagonists; Humans; Piperazines; Vestibule, Labyrinth | 1954 |
STUDIES ON THE EFFECT OF CHLORCYCLIZINE AND OTHER DRUGS ON THE TOXICITY OF SEVERAL ORGANOPHOSPHATE ANTICHOLINESTERASES.
Topics: Brain; Cholinesterase Inhibitors; Cholinesterases; Cyclizine; Enzyme Inhibitors; Esterases; Histamine H1 Antagonists; Liver; Mice; Organophosphate Poisoning; Parathion; Pharmacology; Phenobarbital; Phosphorus; Piperazines; Poisons; Proadifen; Research; Toxicology | 1964 |
GAS CHROMATOGRAPHY OF SOME ANTIHISTAMINES.
Topics: Anti-Allergic Agents; Chemistry, Pharmaceutical; Chlorpheniramine; Chromatography; Chromatography, Gas; Cyclizine; Diphenhydramine; Histamine Antagonists; Histamine H1 Antagonists; Meclizine; Pheniramine; Piperazines; Promethazine; Research; Tripelennamine | 1964 |
PHYSIOLOGICAL DISTRIBUTION AND METABOLIC INACTIVATION OF CHLORCYCLIZINE AND CYCLIZINE.
Topics: Animals; Blood; Blood Proteins; Brain; Chemistry Techniques, Analytical; Chromatography; Cyclizine; Dogs; Histamine H1 Antagonists; Inactivation, Metabolic; Kidney; Liver; Lung; Metabolism; Muscles; Myocardium; Piperazines; Rabbits; Rats; Research; Sex; Spectrophotometry; Spleen | 1965 |